ロード中...
Prime-Boost Vaccination with rBCG/rAd35 Enhances CD8(+) Cytolytic T-Cell Responses in Lesions from Mycobacterium Tuberculosis –Infected Primates
To prevent the global spread of tuberculosis (TB) infection, a novel vaccine that triggers potent and long-lived immunity is urgently required. A plasmid-based vaccine has been developed to enhance activation of major histocompatibility complex (MHC) class I–restricted CD8+ cytolytic T cells using a...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
ScholarOne
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3388130/ https://ncbi.nlm.nih.gov/pubmed/22396020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00222 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|